Halozyme to Report Second Quarter 2022 Financial and Operating Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. BILL
5. MRK
6. MRNA
7. ADI
8. LOW
9. TJX
10. DE

Go back to Halozyme to Report Second Quarter 2022 Financial and Operating Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 106.60 -1.02 (0.95%)
Previous Close $107.62    52 Week High $18.39 
Open $106.41    52 Week Low $6.96 
Day High $107.44    P/E N/A 
Day Low $105.20    EPS $-0.58 
Volume 605,875